Immunogenicity and safety of subunit influenza vaccines in pregnant women

Immunogenicity and safety of subunit influenza vaccines in pregnant women

Pregnancy is a condition of modulated immune suppression, so this group of patients has increased risk of infectious diseases. Trivalent subunit vaccines, unadjusted Agrippal S1 (group I) and immunoadjuvant Grippol Plus (group II), containing 5 μg of actual influenza virus strains, were administered...

Full description

Bibliographic Details
Main Authors:	Mikhail P. Kostinov, Alexander P. Cherdantsev, Nelli K. Akhmatova, Daria A. Praulova, Aristitsa M. Kostinova, Elina A. Akhmatova, Evgeniia O. Demina
Format:	Article
Language:	English
Published:	European Respiratory Society 2018-04-01
Series:	ERJ Open Research
Online Access:	http://openres.ersjournals.com/content/4/2/00060-2017.full

Similar Items

IMMUNOGENICITY OF ADJUVANT INFLUENZA VACCINE FOR PREGNANT WOMEN
by: M. P. Kostinov, et al.
Published: (2017-06-01)

Immunogenicity and Safety of the Quadrivalent Adjuvant Subunit Influenza Vaccine in Seropositive and Seronegative Healthy People and Patients with Common Variable Immunodeficiency
by: Mikhail P. Kostinov, et al.
Published: (2020-11-01)

Cytokine Profile in Human Peripheral Blood Mononuclear Leukocytes Exposed to Immunoadjuvant and Adjuvant-Free Vaccines Against Influenza
by: Mikhail Petrovich Kostinov, et al.
Published: (2020-06-01)

ТHE LEVEL OF ANTIBODIES TO THE INFLUENZA VIRUS IN PREGNANT WOMEN VACCINATED WITH SUBUNIT VACCINE
by: M. P. Kostinov, et al.
Published: (2018-01-01)

Obstetric and perinatal outcomes among pregnant women after influenza vaccination and after transferred respiratory infection
by: M P Kostinov, et al.
Published: (2015-08-01)

Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency
by: Aristitsa Mikhailovna Kostinova, et al.
Published: (2020-08-01)

EFFECT OF INFLUENZA VACCINES ON SUBPOPULATIONS OF BLOOD DENDRITIC CELLS
by: E. A. Chromova, et al.
Published: (2016-10-01)

IMMUNOGENICITY AND SAFETY OF A TRIVALENT SUBUNIT IMMUNOADJUVANT INFLUENZA VACCINE IN CHILDREN WITH TYPE 1 DIABETES: RESULTS OF A PROSPECTIVE COMPARATIVE STUDY
by: Аlla A. Tarasova, et al.
Published: (2016-11-01)

COMPARATIVE ACTIVITY OF INFLUENZA VACCINES: EFFECT ON LYMPHOCYTE SUBPOPULATION STRUCTURE
by: E. A. Chromova, et al.
Published: (2016-12-01)

Nonspecific Regulation of the Number of Immunocompetent Cells Under the Influence of DT Toxoid in Children With Glomerulonephritis
by: Mikhail Petrovich Kostinov, et al.
Published: (2021-10-01)

Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects
by: Pellegrini Michele, et al.
Published: (2008-02-01)

Vaccination of pregnant women against controlled respiratory tract infections
by: A. P. Cherdantsev, et al.
Published: (2020-06-01)

Effect of virulent and vaccine variants of influenza virus on the immunophenotype of dendritic cells generated from murine bone marrow
by: N. K. Akhmatova, et al.
Published: (2020-05-01)

Vaccination Against Diphtheria and Tetanus as a Way to Activate Adaptive Immunity in Children with Solid Tumors
by: Mikhail Petrovich Kostinov, et al.
Published: (2021-07-01)

Comparative Assessment of Reactogenicity and Immunogenicity of Commercial Influenza Inactivated Vaccines: Polymer-Subunit Grippol plus, Subunit Influvac, Split Vaccine Waxigrip
by: S. M. Kharit, et al.
Published: (2017-04-01)

EVALUATION OF IMMUNOLOGICAL SHIFTS IN ADULTS AFTER IMMUNIZATION AGAINST INFLUENZA WITH A SUBUNIT-BASED, ABSORBED MONOVALENT VACCINE STRAIN A/CALIFORNIA/7/2009/(H1N1)
by: M. P. Kostinov, et al.
Published: (2014-07-01)

Enhancement of the immunogenicity and protective efficacy of a mucosal influenza subunit vaccine by the saponin adjuvant GPI-0100.
by: Heng Liu, et al.
Published: (2012-01-01)

Immunogenicity and Efficacy Evaluation of Subunit Astrovirus Vaccines
by: Mehdi R.M. Bidokhti, et al.
Published: (2019-08-01)

Immunogenicity and safety of a trivalent inactivated influenza vaccine
by: Eddy Fadlyana, et al.
Published: (2011-02-01)

First-In-Human Trials of GamTBvac, a Recombinant Subunit Tuberculosis Vaccine Candidate: Safety and Immunogenicity Assessment
by: Daria V. Vasina, et al.
Published: (2019-11-01)

Immunogenicity and Clinical Efficacy Combined Vaccine against Diphtheria, Tetanus and Hepatitis B in Patients with Chronic Obstructive Pulmonary Disease
by: M. P. Kostinov, et al.
Published: (2017-08-01)

New ideas on the therapeutic effect of a combination of vaccines against pneumococcal, Haemophilus influenzae type b infection, and influenza in patients with chronic obstructive pulmonary disease
by: M P Kostinov, et al.
Published: (2015-03-01)

Immunogenicity and Clinical Efficacy of Influenza Vaccination In Pregnancy
by: Alexander W Kay, et al.
Published: (2015-06-01)

New features of pertussis vaccination
by: A. P. Cherdantsev, et al.
Published: (2020-06-01)

Safety of pertussis vaccines for adolescents
by: M. P. Kostinov, et al.
Published: (2020-10-01)

Characterization of influenza vaccine immunogenicity using influenza antigen microarrays.
by: Jordan V Price, et al.
Published: (2013-01-01)

SAFETY AND EFFICIENCY OF INACTIVATED OF SUBUNIT INFLUENZA VACCINE AT MASS VACCINATION OF CHILDREN
by: Yu.Z. Gendon
Published: (2007-09-01)

SAFETY AND EFFICIENCY OF INACTIVATED OF SUBUNIT INFLUENZA VACCINE AT MASS VACCINATION OF CHILDREN
by: Yu.Z. Gendon
Published: (2007-01-01)

Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study
by: Artem P. Tkachuk, et al.
Published: (2020-11-01)

Controlled release microneedle technologies for the enhanced immunogenicity of subunit vaccines
by: Zmolek, Andrew Charles
Published: (2018)

Efficacy and immunogenicity of inactivated influenza vaccine in pregnant women: A randomized, double-blind, placebo controlled trial
by: S. Madhi, et al.
Published: (2014-04-01)

The results of clinical trial on immunogenicity of adjuvanted quadrivalent inactivated subunit influenza vaccine Grippol Quadrivalent in pediatric population 6 to 17 years old
by: Kovtun O.P., et al.
Published: (2020-01-01)

Effect of vitamin D and interferon α-2b on cytokine profile in pregnant women with vaginal infections
by: M. P. Kostinov, et al.
Published: (2020-08-01)

VACCINE-CHALLENGED IMMUNE RESISTANCE TOWARD VIRUS A/CALIFORNIA/7/2009(H1N1)v IN IMMUNIZED PREGNANT WOMEN
by: A. Cherdantsev, et al.
Published: (2014-07-01)

SAFETY OF INACTIVATED POLYMER-SUBUNIT THREE VALENCE INFLUENZA VACCINE. POSTREGISTRATIONAL OBSERVATION
by: S.M. Kharit, et al.
Published: (2009-07-01)

SAFETY OF INACTIVATED POLYMER-SUBUNIT THREE VALENCE INFLUENZA VACCINE. POSTREGISTRATIONAL OBSERVATION
by: S.M. Kharit, et al.
Published: (2009-01-01)

Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity
by: Valentina Agnolon, et al.
Published: (2020-11-01)

Immunogenicity of Concentrated and Purified Inactivated Avian Influenza Vaccine Formulation
by: A. Nazari, et al.
Published: (2018-12-01)

Promoting digital humanitarian action in protecting human rights: hope or hype
by: Dzhennet-Mari Akhmatova, et al.
Published: (2020-06-01)

Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review
by: Amit Bansal, et al.
Published: (2021-10-01)